Philips CEO on 2Q Earnings, M&A, Personal Health Business

The transcript covers Philips' Q2 performance, highlighting a 4% growth in health technology and an 8% increase in order intake. It discusses leadership changes in the personal health business and plans for growth. Philips' M&A strategy, including the acquisition of Spectranetics, is outlined, along with financial strategies like share buybacks. The company plans to divest its Philips Lighting shares to focus on health tech. Rumors of activist investors are addressed, and the impact of US healthcare policy on Philips' operations is discussed.

What was the reported growth in Philips' health technology sector during the second quarter?

• 8%

• 6%

• 4%

• 2%

What is Philips' strategy for the personal health business following Peter Nota's departure?

• Sell the business

• Grow the business

• Merge with another company

• Maintain current operations

Which company did Philips acquire in the second quarter to enhance its portfolio?

• Lumileds

• Certpoint

• Spectranetics

• Volcano

What is Philips' plan regarding its remaining stake in Philips Lighting?

• Merge with another company

• Increase its stake

• Sell down over time

• Maintain current stake

How is Philips addressing the rumors about activist investors?

• By issuing a public statement

• By engaging with shareholders

• By selling shares to new investors

• By ignoring the rumors

What percentage of Philips' revenue comes from the United States?

• 40%

• 35%

• 30%

• 25%

What impact has the uncertainty around the Accountable Care Act had on Philips' U.S. customers?

• No impact

• Decreased order intake

• More careful decision making

• Increased investments